Livzon Pharmaceutical Group Inc. (HKG:1513)
28.40
+1.08 (3.95%)
At close: Mar 6, 2026
11.81% (1Y)
| Market Cap | 31.72B |
| Revenue (ttm) | 12.95B |
| Net Income (ttm) | 2.34B |
| Shares Out | n/a |
| EPS (ttm) | 2.61 |
| PE Ratio | 13.55 |
| Forward PE | 12.54 |
| Dividend | 1.20 (4.24%) |
| Ex-Dividend Date | Jun 13, 2025 |
| Volume | 735,000 |
| Average Volume | 795,788 |
| Open | 27.44 |
| Previous Close | 27.32 |
| Day's Range | 27.44 - 28.40 |
| 52-Week Range | 24.85 - 41.85 |
| Beta | 0.37 |
| RSI | 44.26 |
| Earnings Date | Mar 24, 2026 |